Purple Biotech Financials
| KTOV Stock | ILA 5.50 0.20 3.77% |
Purple |
Please note, the presentation of Purple Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Purple Biotech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Purple Biotech's management manipulating its earnings.
Purple Biotech Stock Summary
Purple Biotech competes with Blender Financial, Clal Insurance, Wesure Global, Priortech, and Abra Information. Kitov Pharma Ltd, a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. The company was formerly known as Kitov Pharmaceuticals Holdings Ltd. and changed its name to Kitov Pharma Ltd in January 2018. KITOV PHARMA operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 9 people.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0007650166 |
| Business Address | One Azrieli Center, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.kitovpharma.com |
| Phone | 972 3 933 3121 |
| Currency | ILA |
You should never invest in Purple Biotech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Purple Stock, because this is throwing your money away. Analyzing the key information contained in Purple Biotech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Purple Biotech Key Financial Ratios
Purple Biotech's financial ratios allow both analysts and investors to convert raw data from Purple Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of Purple Biotech over time and compare it to other companies across industries.| Return On Equity | -0.92 | |||
| Return On Asset | -0.0915 | |||
| Beta | 2.04 |
Purple Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Purple Biotech's current stock value. Our valuation model uses many indicators to compare Purple Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Purple Biotech competition to find correlations between indicators driving Purple Biotech's intrinsic value. More Info.Purple Biotech is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Purple Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Purple Biotech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Purple Biotech Systematic Risk
Purple Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Purple Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Purple Biotech correlated with the market. If Beta is less than 0 Purple Biotech generally moves in the opposite direction as compared to the market. If Purple Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Purple Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Purple Biotech is generally in the same direction as the market. If Beta > 1 Purple Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Purple Biotech Thematic Clasifications
Purple Biotech is part of IT investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains
This theme covers Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains. Get More Thematic Ideas
| IT | View |
Purple Biotech March 2, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Purple Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Purple Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Purple Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Purple Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Purple Biotech's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.26 | |||
| Information Ratio | 0.0423 | |||
| Maximum Drawdown | 105.74 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 12.77 |
Complementary Tools for Purple Stock analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |